Ans: A. Drug safety(Ref Goodman Gilman 12/e p79; .Katzung 13/e p12, 12/e p75; KDT 7/e p63-64, 6/e p77)Safety, pharmacodynamics & dosing - Tested in Phase 1 clinical trial.Drug safety - Most impoant primary end point.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.